| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |